Barbara Warren
Ufficiale delle Risorse Umane presso KINNATE BIOPHARMA INC.
Provenienza dei contatti di primo grado di Barbara Warren
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 21 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Barbara Warren tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PG&E Enterprises | Corporate Officer/Principal | ||
| BLACKBERRY LIMITED | Packaged Software | Director/Board Member | |
| CAREDX, INC | Medical Specialties | Director of Finance/CFO | |
| HUMANIGEN, INC. | Biotechnology | Director/Board Member | |
| PRECIGEN, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Internet Software/Services | Chairman Corporate Officer/Principal Chief Executive Officer General Counsel | |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Undergraduate Degree | |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Financial Conglomerates | Analyst-Equity | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Undergraduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Chief Executive Officer | |
The New York City Investment Fund Manager, Inc.
 The New York City Investment Fund Manager, Inc. Investment ManagersFinance The New York City Investment Fund Manager Inc. (The New York City Investment Fund Manager) is a venture capital firm founded by Henry Kravis in 1996. The firm is headquartered in New York, United States. | Investment Managers | Consultant / Advisor | |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Sales & Marketing General Counsel | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Can Do Multiple Sclerosis
 Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Can Do Multiple Sclerosis provides lifestyle empowerment programs. The company was founded in 1984 and is located in Edwards, CO. | Miscellaneous Commercial Services | Director/Board Member | |
| THERAVANCE BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree | |
PharmApprove LLC
 PharmApprove LLC Miscellaneous Commercial ServicesCommercial Services PharmApprove LLC provides strategic regulatory and scientific communications consultancy services to the pharmaceutical and biotech industries. The firm offers both strategic and tactical support to companies facing high-profile, high stakes events and engagements anywhere along the road to approval and commercialization -including FDA Advisory Committee meetings. The company was founded by Pete Taft in 1999 and is headquartered in Lawrenceville, NJ. | Miscellaneous Commercial Services | President | |
| ARVINAS, INC. | Biotechnology | Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| PRAXIS PRECISION MEDICINES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Founder | |
Frontera Therapeutics (HK) Ltd.
 Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company was founded by Yong Dai and Yong Dai has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| PARDES BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
| Paxvax Corp. | Chairman Chief Executive Officer | ||
| Kalobios Pharmaceuticals, Inc. | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 47 |
| Canada | 3 |
| Svezia | 2 |
| Hong Kong | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 4 |
| Technology Services | 3 |
Posizioni
| Director/Board Member | 160 |
| Independent Dir/Board Member | 47 |
| Corporate Officer/Principal | 43 |
| Chief Executive Officer | 21 |
| Founder | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Carl Gordon | 59 |
| Dean Mitchell | 22 |
| Stephen W. Kaldor | 16 |
| Keith Flaherty | 16 |
| Laurie Alsup | 14 |
| Melissa Epperly | 13 |
| David Madden | 12 |
| Jill DeSimone | 12 |
| Nima Farzan | 12 |
| Michael Rome | 9 |
| Mark Meltz | 8 |
| Helen Sabzevari | 6 |
| Richard Williams | 6 |
| Eric Murphy | 5 |
- Borsa valori
- Insiders
- Barbara Warren
- Connessioni Società
